Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Azithromycin patent?

See the DrugPatentWatch profile for Azithromycin

The patent status of azithromycin is complex, as it is an older drug with many patents that have already expired. The original composition of matter patent for azithromycin expired in 2004. [1] However, secondary patents related to specific formulations, methods of use, or manufacturing processes may still be in effect for certain indications. [2]

When does the primary azithromycin patent expire?


The fundamental patent protecting azithromycin as a chemical entity expired in 2004. [1] This means that generic versions of azithromycin have been available for a significant period.

Are there still patents for azithromycin?


While the core patent has expired, it is possible for patents on new formulations, manufacturing methods, or specific therapeutic uses of azithromycin to exist. DrugPatentWatch.com tracks such patent information for various drugs. [3] Companies may seek patents for improvements or novel applications of existing drugs.

Who makes generic azithromycin?


Numerous pharmaceutical companies produce generic versions of azithromycin, making it widely available and affordable. [4] The expiration of its primary patent allowed for the entry of many generic manufacturers into the market.

What is azithromycin used for?


Azithromycin is a macrolide antibiotic used to treat a variety of bacterial infections. [5] These include respiratory tract infections such as pneumonia and bronchitis, skin and soft tissue infections, and certain sexually transmitted infections. [5]

How does azithromycin work?


Azithromycin works by inhibiting bacterial protein synthesis. It binds to the 50S ribosomal subunit of susceptible bacteria, preventing the translocation of aminoacyl-tRNA and inhibiting peptide chain elongation. [6] This ultimately leads to the disruption of essential bacterial functions and cell death.

What are the common side effects of azithromycin?


Common side effects associated with azithromycin include diarrhea, nausea, abdominal pain, and vomiting. [7] Less common side effects may include dizziness, headache, and rash. [7]

Are there alternative antibiotics to azithromycin?


Yes, depending on the type of infection and individual patient factors, alternative antibiotics may be used. These can include other macrolides like erythromycin or clarithromycin, as well as different classes of antibiotics such as penicillins, cephalosporins, or fluoroquinolones. [8] The choice of antibiotic is determined by the specific pathogen, its susceptibility, and patient allergies or contraindications.

What is the regulatory status of azithromycin?


Azithromycin is an approved medication in many countries and is available both by prescription and, in some formulations and dosages, over-the-counter. [9] Its approval status is managed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

What are the risks of taking azithromycin?


While generally safe, azithromycin can pose risks, particularly for individuals with certain pre-existing conditions. These include potential cardiac issues, such as QT interval prolongation, which can lead to irregular heartbeats. [10] Liver problems and allergic reactions are also possible, though rare. [10]

---

Sources:

[1] https://drugpatentwatch.com/
[2] https://drugpatentwatch.com/
[3] https://drugpatentwatch.com/
[4] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?fuseaction=getAPPROVAL
[5] https://www.nhs.uk/medicines/azithromycin/
[6] https://pubmed.ncbi.nlm.nih.gov/12924902/
[7] https://www.nhs.uk/medicines/azithromycin/
[8] https://www.cdc.gov/antibiotic-use/azithromycin.html
[9] https://www.ema.europa.eu/en
[10] https://www.nhs.uk/medicines/azithromycin/



Other Questions About Azithromycin :

how much is azithromycin without insurance Azithromycin 500mg rate? Azithromycin with advil? Azithromycin 250 price? How much is azithromycin in nigeria? Ingredients in azithromycin? Azithromycin price philippines generics pharmacy?

AI-Drug Label Prescribing Information Alignment Report

60
60%
Grade C

Partial

Mostly Not Aligned

Patient Risk: Low

Summary

Only a stewardship-style claim is supported by the provided FDA label excerpts (use for proven/strongly suspected susceptible bacterial infections). Most other claims made are not evaluated against, nor supported by, the supplied label text excerpts, so overall alignment is partial.


Category Scores

Indication
70
Good
Warnings
60
Good

Accurate Statements

To reduce the development of drug-resistant bacteria and maintain effectiveness, Zmax should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.
Supported by label section 1 INDICATIONS AND USAGE and reinforced by 5.6 Development of drug resistant bacteria and 17.1 General Patient Counseling.

Unsupported Statements

Azithromycin is a macrolide antibiotic.
Not supported by the provided label excerpts.
Azithromycin is used to treat a variety of bacterial infections.
Not supported by the provided label excerpts (only specific indications listed in the excerpt are visible, not a broad 'variety' statement).
Azithromycin is used to treat respiratory tract infections such as pneumonia and bronchitis.
The excerpt supports community-acquired pneumonia and acute bacterial sinusitis, but does not mention bronchitis; 'such as' makes this broader than the provided label text.
Azithromycin is used to treat skin and soft tissue infections.
Not supported by the provided label excerpts.
Azithromycin is used to treat certain sexually transmitted infections.
Not supported by the provided label excerpts.
Azithromycin works by inhibiting bacterial protein synthesis.
Mechanism-related details are not present in the provided label excerpts.
Azithromycin binds to the 50S ribosomal subunit of susceptible bacteria.
Mechanism details are not present in the provided label excerpts.
Azithromycin prevents the translocation of aminoacyl-tRNA.
Mechanism details are not present in the provided label excerpts.
Azithromycin inhibits peptide chain elongation.
Mechanism details are not present in the provided label excerpts.
Azithromycin disrupts essential bacterial functions and leads to cell death.
Not supported by the provided label excerpts.
Common side effects of azithromycin include diarrhea, nausea, abdominal pain, and vomiting.
Adverse reactions/side effects are not present in the provided label excerpts.
Less common side effects of azithromycin may include dizziness, headache, and rash.
Adverse reactions/side effects are not present in the provided label excerpts.
Azithromycin can pose risks including potential cardiac issues such as QT interval prolongation that can lead to irregular heartbeats.
Cardiac/QT-related warnings are not present in the provided label excerpts.
Liver problems are possible with azithromycin.
Hepatic/liver warnings are not present in the provided label excerpts.
Allergic reactions are possible with azithromycin.
Hypersensitivity/allergy statements are not present in the provided label excerpts.
Azithromycin is an approved medication in many countries.
Regulatory approval geography is not present in the provided label excerpts.
Azithromycin is available by prescription.
Marketing/access/regulatory dispensing status is not present in the provided label excerpts.
In some formulations and dosages, azithromycin is available over-the-counter.
OTC availability is not present in the provided label excerpts.
Approval status of azithromycin is managed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
This is not stated in the provided label excerpts.
The original composition of matter patent for azithromycin expired in 2004.
Patent/market exclusivity history is not present in the provided label excerpts.
Secondary patents related to specific formulations, methods of use, or manufacturing processes may still be in effect for certain indications of azithromycin.
Patent status details are not present in the provided label excerpts.
Generic versions of azithromycin have been available for a significant period due to expiration of its primary patent.
Market authorization/history is not present in the provided label excerpts.
Patents on new formulations, manufacturing methods, or specific therapeutic uses of azithromycin may exist even after the core patent has expired.
Patent status details are not present in the provided label excerpts.
Numerous pharmaceutical companies produce generic versions of azithromycin.
Manufacturer/market landscape is not present in the provided label excerpts.

Contradictions


Important Omissions

If the AI response intended to focus on Zmax specifically, it should use the label’s exact stewardship language (proven/strongly suspected susceptible bacterial infection) rather than making additional broad claims not present in the provided label excerpts.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only label-supported substantive claim provided is an antimicrobial stewardship restriction (use only for proven/strongly suspected susceptible bacterial infections). Other claims are unsupported by the supplied excerpts rather than directly contradicting safety statements; however, unsupported broadened therapeutic/side effect/patent/availability statements could mislead if relied upon.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Mostly Not Aligned

Primary Issue
Most claims (mechanism, adverse effects, specific indications like bronchitis/skin/sexually transmitted infections, and regulatory/patent/availability statements) are not supported by the provided FDA label excerpts.

Suggested Improvement
Limit claims to what is present in the supplied label text (e.g., stewardship restriction in Indications/Usage and Warnings 5.6) and avoid adding mechanism, adverse reaction, and broad indication statements unless supported by the provided prescribing information sections.

Drug Brand Mention Assessment

Branding Score
52
Visibility
57
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

a macrolide antibiotic used to treat a variety of bacterial infections


Core Claims
  • The patent status of azithromycin is described as complex.
  • The original composition of matter patent for azithromycin expired in 2004.
  • Generic versions of azithromycin have been available for a significant period.
  • Azithromycin is a macrolide antibiotic used to treat bacterial infections.
  • Azithromycin can pose risks including potential cardiac issues like QT interval prolongation.
Differentiators

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Erythromycin 0%
0 # No
Clarithromycin 0%
0 # No
Penicillins 0%
0 # No
Cephalosporins 0%
0 # No
Fluoroquinolones 0%
0 # No